Greenwich Capital Group：2026年Q1医疗行业并购动态报告（英文版）

Healthcare M&A entered 2026 with momentum driven by accelerating adoption of artificial intelligence, continued investment in digital health capabilities, and growing commercial activity surrounding GLP-1- related products and services. Buyers have increasingly focused on assets that can enhance operational efficiency, improve patient engagement, or strengthen technology-enabled care. Transaction activity continued to be led by strategic acquirers seeking to expand their capabilities and